Racial and ethnic differences in patient ratings of colorectal and non-small-cell lung cancer care: A SEER-CAHPS study

Cancer Causes Control. 2022 Sep;33(9):1125-1133. doi: 10.1007/s10552-022-01606-6. Epub 2022 Jul 21.

Abstract

Purpose: Although significant racial and ethnic disparities exist in colorectal and lung cancer treatment and survival, racial differences in patient-reported experience of care are not well understood. The purpose of this study was to examine differences in patient-reported ratings of colorectal and non-small-cell lung cancer care by race/ethnicity.

Methods: Medicare beneficiaries with AJCC stage I-IV colorectal and non-small-cell lung cancer (2003-2013) who completed a Medicare Consumer Assessment of Healthcare Providers (CAHPS) survey within 5 years of cancer diagnosis were identified in the linked SEER-CAHPS dataset. Scores were compared by race/ethnicity, defined as White, Black, or any other race/ethnicity.

Results: Of the 2,621 identified patients, 161 (6.1%) were Black, 2,279 (87.0%) White, and 181 (6.9%) any other race/ethnicity. Compared to White patients, Black patients were younger, had lower educational level, and had higher census tract poverty indicator (p < 0.001). Black patients rated their ability to get care quickly significantly lower than White patients (63.5 (SE 3.38) vs. 71.4 (SE 2.12), p < 0.01), as did patients of any other race/ethnicity (LS mean 66.2 (SE 2.89), p = 0.02). Patients of any other race/ethnicity reported their ability to get needed care significantly lower than White patients (LS mean 81.9 (SE 2.46) vs. 86.7 (SE 1.75), p = 0.02); however, there was no difference in ability to get needed care between Black and White patients.

Conclusion: Patient ratings for getting care quickly were lower in non-White patients, indicating racial disparities in perceived timeliness of care.

Keywords: Colon cancer; Health disparities; Health services research; Patient-reported experience; Race/ethnicity.

MeSH terms

  • Aged
  • Carcinoma, Non-Small-Cell Lung* / therapy
  • Colorectal Neoplasms* / therapy
  • Ethnicity
  • Humans
  • Lung Neoplasms* / therapy
  • Medicare
  • United States / epidemiology